OPTH logo

OPTIMI HEALTH CORP

OPTHNASDAQ
US Equity
$4.78▼ $0.06 (−1.24%)
After hours · at close
🔔
Track OPTH
Get earnings, price moves & breaking news on Telegram
Track
24h▼ 1.2%
7d▼ 4.6%
14d▼ 6.4%
30d▼ 3.8%
ytd—
1y—
🏦Market Cap
$27M
Small Cap
📈Revenue Growth (YoY)
-57.8%
Declining
📊Gross Margin
65.1%
High
💵FCF Margin
—
⚖️P/S Ratio
163.6x
Expensive
Otter Score
72
Fair

Trading Snapshot

Day Range
$4.73 – $4.86
52-Week Range
—
Volume
$2.61B
Avg Volume
$3.22B
Shares Outstanding
5.7M
Next Earnings
Dec 13, 2026

Fundamentals Snapshot

Annual Revenue
$426,904
Last Q Revenue
$98,700
P/E Ratio
—
P/S Ratio
163.6x
EPS (TTM)
—
Dividend Yield
—
Dilution (1yr)
+7.9%

Why Investors Own OPTH

  • ✓High-growth profile — revenue up +48.4% YoY with expanding US Equity exposure.
  • ✓Healthy economics — 53% gross margin and 11% free-cash-flow margin.
  • ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

OPTH logo

OPTIMI HEALTH CORP

OPTH
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$427K▲ +9.5% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
-486.4%▼ −800.0% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$5M▼ −19.2% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$3M▼ −38.7% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
3.2M▲ +7.9% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
−$6M▼ −$3M YoY
StockOtter · stockotter.space

About OPTIMI HEALTH CORP

Based in Princeton, Canada, Optimi Health Corp., established in 2020, is a Canadian entity focused on manufacturing pharmaceutical and nutraceutical products. The company produces and supplies controlled substances, including finalized MDMA and psilocybin drug products, directly to authorized clinics, pharmacies, research trials, and collaborative partners. Their diverse product portfolio extends to MDMA, natural psilocybin, psilocin, other psychedelic compounds, and functional mushrooms, all derived from botanical sources and aimed at the health and wellness market. Optimi Health's operations span cultivation, processing, and distribution of raw mushroom biomass, alongside the creation of mushroom extracts, pharmaceutical drug products, and dietary supplements. These items are available for purchase through the Amazon marketplace, via distributors and brokers, and directly online.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)
💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Fair
72/100

Analyst Price Target

ⓘ
Average Target
$5.32
▲ +11.4% Upside
High Target$5.79
Low Target$4.23
Based on 36 analysts

Latest News & Updates

🚀
CNBC·2h ago

OPTIMI HEALTH CORP tops quarterly estimates as demand accelerates

Revenue grew double digits with management guiding above consensus; margins continued to expand.

🛰️
Barron’s·5h ago

Analysts lift OPTH price targets on improving margins

Several firms raised targets, citing stronger free cash flow and a healthier backlog.

🌌
Barron’s·1d ago

OPTIMI HEALTH CORP announces new agreement to expand its footprint

The move broadens the company’s reach and could add incremental revenue over the next year.